# Krystal Biotech, Inc.: Form 8-K, filed May 20, 2026

- Company: [Krystal Biotech, Inc.](/companies/krys.md) (CIK 1711279)
- Form: 8-K
- Filed: 2026-05-20
- Accepted by EDGAR: May 19, 2026, 20:08 ET
- Period: 2026-05-15
- Accession: 0001711279-26-000047
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1711279/000171127926000047/krys-20260515.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1711279/000171127926000047/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1711279/000171127926000047/krys-20260515.htm

Filed May 20, 2026.
Source: SEC EDGAR, the filing index for accession 0001711279-26-000047. Last ingested by Listed: Nov 14, 2026, 22:22 ET. No prices; not investment advice.
